POLYMYXIN B (Xellia Pharmaceuticals ApS)
Welcome to the PulseAid listing for the POLYMYXIN B drug offered from Xellia Pharmaceuticals ApS. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Xellia Pharmaceuticals ApS |
| NON-PROPRIETARY NAME: | POLYMYXIN B SULFATE |
| SUBSTANCE NAME: | POLYMYXIN B SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |
| ROUTE: | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-01-24 |
| END MARKETING DATE: | 0000-00-00 |
POLYMYXIN B HUMAN PRESCRIPTION DRUG Details:
| Item Description | POLYMYXIN B from Xellia Pharmaceuticals ApS |
| LABELER NAME: | Xellia Pharmaceuticals ApS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500000(1-Jan) |
| START MARKETING DATE: | 2014-01-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45932-0030_5039c2fa-cc43-4787-933c-a9943ca381eb |
| PRODUCT NDC: | 45932-0030 |
| APPLICATION NUMBER: | ANDA202766 |
Other POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:
